Cannabis Report
Home > Boards > US OTC > Medical - Equipment >

Lifeline Biotechnologies, Inc. (LLBO)

Add LLBO Price Alert      Hide Sticky   Hide Intro
Moderator: Arnie1, stjean17, leprisonnier, MEAD II, rmilman
Search This Board: 
Last Post: 8/21/2018 5:20:18 PM - Followers: 268 - Board type: Free - Posts Today: 0

Lifeline Biotechnologies Provides Information To The Public And Its Shareholders

Cyrcadia, Inc. – 2017 Year End and 2018 Look Forward Newsletter

by admin | Feb 21, 2018 | NewsFebruary 27, 2018 Cyrcadia, Inc. (“CI”) extends its thanks and appreciation in your interest and support of our endeavors. We are taking this opportunity to provide an update, as well as apprise you of upcoming expectations. License and Cooperation Agreement with Cyrcadia Asia (“CA”) – Status Earlier in 2017 CI entered into an Agreement with CA, whereby CA assumed the responsibility and funding of the design, development and delivery of a scalable, commercializable iTBra™ system including upgraded hardware and the full suite of application software as well as automation of our proprietary Artificial Intelligence Analytics. The estimated cost of development with Jabil and Mobile Now is approximately $1.2 to $1.5 million US. As such, the agreement calls for CA to provide timely reporting and status of product development including timelines, milestones and dates of completion and delivery of product (market readiness, product volume availability and delivery terms and schedules). Many strides have been made in the evolution of the relationship as CA has established its operations, initial staffing and funding. Both CI and CA are in a mode of cooperation, as called for by the Agreement and, presently, both entities are to hold routine meetings where comprehensive updating and reporting will be delivered to CI, enabling implementation of our business, operations and marketing plans. We will be reporting the outcomes of that meeting to move forward on our ability to commercialize the iTBra™ system this year. Given the above, we would like to update on the internal operations that will allow for CI to “hit the ground running” upon product delivery. Status of Product Development and Manufacturing Under CA’s...

Welcome to Lifeline Biotechnologies Inc. (LLBO) Board!!!

Clinical Trial

In Progress - To Be Completed

** Funding for Clinical Trial

** Vendor delivery of testing materials

Completed for Clinical Trial

** Protocol for testing accepted

** Internal Review Board (IRB) approved

** Contract with hospital executed

Prospective Partner

** Stanford University's Canary Research

Research in blood genomics


The Mastascope is an ultraslim, hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast. Because many cancers actually begin within an individual milk duct, these intraductal tumors are visualized easily and can be biopsied. This product has been used in leading breast centers in the United Kingdom and other countries with great success. Lifeline has obtained a CE mark for marketing and distribution in Europe. 


Lifeline has developed and tested an ultraslim endoscope to directly visualize the ovarian surface in the search for cancer. This is of great advantage to physicians, because neither MRI, X-Ray nor Ultrasonography can provide accurate assessments of subtle surface changes. Initial reports of clinical usage have been encouraging.

About $LLBO - Lifeline Biotechnologies, Inc.

About Lifeline Biotechnologies:

Lifeline Biotechnologies, Inc. (OTC Market: LLBO) founded in 1994 is based in Reno, NV.  LLBO has invested over $10M in a device and process for early detection of breast tissue abnormalities some of which are cancerous or pre-cancer.  Three “Proof of Concept” clinical trials of over 500 women have been completed and three patents (one hardware, two software) have been awarded. 

Safe Harbor:

This publication includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, the ability to obtain financing, successful development of the Company's product or market acceptance of the product and regulatory and shareholder approval for anticipated actions. became Cyrcadia Health

$LLBO is Cyrcadia's largest shareholder at approximately 40%

Transfer Agent

OTC Corporate Transfer Service Co.
52 Maple Run Drive
Jericho, NY 11753

Share Structure
Shares Outstanding 3,026,680,967 a/o Sep 30, 2014
Float 650,000,000 a/o Jun 30, 2009
Authorized Shares 4,950,000,000 a/o Sep 30, 2014
Par Value 0.001

Company Information

About Lifeline Biotechnologies:

Lifeline Biotechnologies, Inc. (OTC Market: LLBO) founded in 1994 is based in Reno, NV.  LLBO has invested over $10M in a device and process for early detection of breast tissue abnormalities some of which are cancerous or pre-cancer.  Three “Proof of Concept” clinical trials of over 500 women have been completed and three patents (one hardware, two software) have been awarded.

About Cyrcadia Health

Cyrcadia Health founded in 2008, is based in Reno, Nev. The Cyrcadia Health product line is a device and software service that detects breast tissue abnormalities leading to health risk assessment and management including early breast cancer identification. Three clinical trials with over 650 participants have achieved proof of concept and superior outcomes when compared to other diagnostic protocols. Cyrcadia Health technology is exclusively licensed for development, manufacturing and marketing worldwide from Lifeline Biotechnologies, Inc (OTC Market: LLBO). Cyrcadia Health is planning a final, limited clinical trial and a 510k device classification to validate the fourth generation of the FWS product. Cyrcadia Health is preparing to apply for a Euro CE Mark to market in the European Union and Asia Pacific markets. See Cyrcadia Health video, “Breast Cancer Tumor Progression” at

iTBra in the News

ABC 7 News - February 5, 2015


ABC 7 News - February 5, 2015

ABC 7 News - January 30, 2015

Good Monring America apperance coming....
Quote from the March 12, 2015 PR

They also interviewed Rob Royea (Cyrcadia's President) for a feature story on Good Morning America expected to air in the next coming months.

Could a Bra Actually Detect Breast Cancer?
By Smithsonian Magzine



Documentary Movie: Detected coming....
Funded by Cisco
Detected Trailer...

Detected trailer on Cisco's facebook page
Detected: Behind the Scenes with Ironbound Films
Meet Chief Evangelist Behind Cancer-Detecting iTBra, Rob Royea

How the Internet of Everything is Changing Healthcare

Can the IoE Save Lives? Connected Bra Could Predict Cancer
By: Cisco's Senior Vice President and Chief Marketing Officer

Detected Website
Detected Facebook
Detected Twitter

Partnered with Flextronics

Cyrcadia Health Partners

In Israel at Flextronics


iTBra Already Saved Nedra Lindsay's Life - See Her Story

Final Clinical Trials, FDA plans and other info from - March 12, 2015 Press Release

...Cyrcadia prepares to enter the final clinical trials that will be conducted at El Camino Hospital (ECH) in Mountain View, CA and the Ohio State University (OSU) Oncology Hospital in Columbus, OH. The trials have been approved through Investigational Review Boards (IRB's) of ECH and are currently undergoing the review process at OSU. The ECH trial is slated for start before the end of April 2015. The trials are expected to be completed in four to 6 months. On completion Cyrcadia will obtain CE Marking allowing for sales and marketing outside of the USA. On completion of the trials Cyrcadia will be submitting a 510(k) to the FDA. Post clearance, marketing will begin in the USA. International sales are expected in Q4 of 2015 and US sales in Q1 or Q2 of 2016.


It is interesting to note that Dr. Farrar at OSU will be the primary investigator for the trials conducted at OSU. Dr. Farrar headed the original "proof of concept" study that was conducted at OSU.


Stanford University Canary Center for Early Cancer Detection has pledged $187,000 to help fund the equipment for the trials at El Camino Hospital.


They also interviewed Rob Royea (Cyrcadia's President) for a feature story on Good Morning America expected to air in the next coming months.


Detected Movie Youtube channel
Video News Clipping ABC7 Los Angeles Health News - Breast Cancer Detecting Bra
Detected: Behind the Scenes with Ironbound Films
Wearable & Social Breast Cancer Screening
Meet Chief Evangelist Behind Cancer-Detecting iTBra, Rob Royea
How the Internet of Everything is Changing Healthcare
GameChanger of the Year: Cyrcadia

$LLBO infograph, DD in a nutshell

Cannabis Report
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#25922  Sticky Note “New”Investor Information: confirm 07/17/18 08:30:45 AM
#26406   I agree all talks, no facts. All indications Arnie1 08/21/18 05:20:18 PM
#26405   Loop as in round of Golf. Objective is confirm 08/21/18 04:27:13 PM
#26404   may be worth listening in sven 08/21/18 04:07:28 PM
#26403   Exactly, cannot understand why anyone would wanna bash stjean17 08/21/18 03:59:37 PM
#26402   That's an interesting point and yes many people MEAD II 08/21/18 02:05:25 PM
#26399   Lefty you are so very right! And in MEAD II 08/21/18 11:34:13 AM
#26398   I’ll admit this is frustrating to no end LEFTY1182 08/21/18 10:50:20 AM
#26397   PB and yet another original insight and another MEAD II 08/21/18 10:37:44 AM
#26396   We should be trading at .05 now PharrmaBro 08/21/18 10:23:42 AM
#26395   Was my post removed???? E-7-2 08/20/18 10:34:10 PM
#26386   Don’t be caught at the airport... confirm 08/20/18 09:35:37 AM
#26385   Rocked and ready, slow and steady. Is stjean17 08/19/18 09:43:12 PM
#26384   Droopy you have the right to your opinion. MEAD II 08/19/18 07:09:43 PM
#26383   The progress of LLBO is tied to the MEAD II 08/19/18 07:07:17 PM
#26382   What a scam imo droopyeyes 08/19/18 06:03:54 PM
#26381   It was a typo! We should start marketing Arnie1 08/19/18 05:35:01 PM
#26380   Is that “agree” in Italian? LEFTY1182 08/19/18 05:18:12 PM
#26379   I agreeIi Arnie1 08/19/18 05:06:45 PM
#26378   Let’s get this board cranking! We need to LEFTY1182 08/19/18 04:50:55 PM
#26377   BME - if I pre-judge you as Arnie1 08/19/18 04:28:53 PM
#26376   Arnie1. You have made a mistake to judge bme 08/19/18 03:19:11 PM
#26375   BME - it appears that you are a Arnie1 08/19/18 09:39:04 AM
#26374   New Article on the web today about Y bme 08/18/18 09:17:21 PM
#26373   Great job yes u can’t trade this this xd456xd 08/17/18 09:28:49 PM
#26372   LLBO is not a stock to TRADE. LLBO MEAD II 08/17/18 01:47:04 PM
#26371   Really bad trading stock cuti2011 08/17/18 01:23:35 PM
#26370   iFlytec(Keda Xunfei) & Cyrcadia Health confirm 08/17/18 12:50:14 PM
#26369   Agreed! Great things are in the near rrao11 08/17/18 11:57:58 AM
#26368   I-HUB Message Board shows the same thing. Zero MEAD II 08/17/18 11:28:36 AM
#26367   Fidelity is showing ‘0’ volume. Is LLBO rrao11 08/17/18 11:21:35 AM
#26366   I do agree that it is more than MEAD II 08/17/18 08:30:50 AM
#26365   Lefty, I agree Cisco a possibility...Also, iFlytec Co. confirm 08/17/18 07:55:16 AM
#26364   Hopefully Cisco buys this thing out in the LEFTY1182 08/17/18 03:29:25 AM
#26363   News, the only new news I’ve seen is confirm 08/16/18 01:19:31 PM
#26362   That is a very good point. MEAD II 08/16/18 10:59:45 AM
#26361   Thanks Arnie I appreciate your advice, support and MEAD II 08/16/18 10:58:23 AM
#26360   Breast Cancer awareness month in 6 weeks .Cyrcadia intexp 08/16/18 09:40:22 AM
#26359   Think positive!! Great things are coming: product Launch,FDA Arnie1 08/16/18 09:33:40 AM
#26358   What was the alleged news that you were MEAD II 08/16/18 08:45:18 AM
#26357   There are so many big players involved with brogger 08/16/18 07:45:34 AM
#26356   I don’t know what news your looking Cyrcadia xd456xd 08/16/18 06:48:31 AM
#26355   Me too, Something smells not good.. It takes too yaro1 08/16/18 03:51:35 AM
#26354   Brother... STAY CALM my friend. Chaka 08/16/18 02:58:31 AM
#26353   I'm very disappointed... Leaves me to consider. Take voo 08/16/18 02:49:53 AM
#26352   No still hope after market... voo 08/15/18 04:36:02 PM
#26351   Are you sure about the no news?? yaro1 08/15/18 04:00:55 PM
#26350   Here is the CH website news link: MEAD II 08/15/18 03:34:20 PM
#26349   I encourage all LLBO long investors to visit MEAD II 08/15/18 03:15:43 PM
#26348   Guys, we have now reached the half way E-7-2 08/15/18 02:48:51 PM
#26347   Thanks!, Appreciate it!, Arnie1 08/15/18 02:02:51 PM